{"transactions":[{"id":754244,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2026-06-02T20:11:11.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vested on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vested on May 29, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001377832-26-000005","document":"wk-form4_1780431068.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000137783226000005/wk-form4_1780431068.xml","form_type":"4"}},{"id":754243,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-02T20:11:11.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":34604,"source":{"system":"sec-edgar","filing":"0001377832-26-000005","document":"wk-form4_1780431068.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000137783226000005/wk-form4_1780431068.xml","form_type":"4"}},{"id":904836,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-13T21:20:08.000Z","date":"2026-02-13","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":23.9586,"value":239586.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average purchase price of these transactions was $23.9586 per share, with a range of $23.7600 to $23.9999 per share. Upon request, the Reporting Person hereby undertakes to provide\nto staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price."}],"balance_after":27775,"source":{"system":"sec-edgar","filing":"0001377832-26-000003","document":"wk-form4_1771017605.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000137783226000003/wk-form4_1771017605.xml","form_type":"4"}},{"id":946306,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-01-06T21:27:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests in four substantially equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":6354,"derivative":{"exercise_price":6.46,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":6354},"source":{"system":"sec-edgar","filing":"0000905148-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000073/form4.xml","form_type":"4"}},{"id":946305,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-01-06T21:27:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs vest in four equal installments on March 31, June 30, September 30 and December 31, 2026, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":6804,"derivative":{"underlying":"Common Stock","underlying_shares":6804},"source":{"system":"sec-edgar","filing":"0000905148-26-000073","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514826000073/form4.xml","form_type":"4"}},{"id":1127308,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-06-02T20:13:03.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":6829,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units will vest on May 29, 2026."}],"balance_after":6829,"derivative":{"underlying":"Common Stock","underlying_shares":6829},"source":{"system":"sec-edgar","filing":"0001906324-25-000122","document":"wk-form4_1748895176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000190632425000122/wk-form4_1748895176.xml","form_type":"4"}},{"id":1133044,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2025-05-27T20:28:44.000Z","date":"2025-05-22","kind":"exercise","planned":false,"acquired":false,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vested on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vested on May 22, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4929},"source":{"system":"sec-edgar","filing":"0001906324-25-000099","document":"wk-form4_1748377717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000190632425000099/wk-form4_1748377717.xml","form_type":"4"}},{"id":1133043,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-27T20:28:44.000Z","date":"2025-05-22","kind":"grant","planned":false,"acquired":true,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":17775,"source":{"system":"sec-edgar","filing":"0001906324-25-000099","document":"wk-form4_1748377717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000190632425000099/wk-form4_1748377717.xml","form_type":"4"}},{"id":1136972,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-22T20:16:43.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":42010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer."}],"balance_after":42010,"derivative":{"exercise_price":0.2708,"expiration_date":"2035-05-19","underlying":"Common Stock","underlying_shares":42010},"source":{"system":"sec-edgar","filing":"0000905148-25-001897","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001897/form4.xml","form_type":"4"}},{"id":1136971,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-22T20:16:43.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":80525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of the Issuer's common stock (\"Common Stock\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in three substantially equal installments on June 30, September 30 and December 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":80525,"derivative":{"underlying":"Common Stock","underlying_shares":80525},"source":{"system":"sec-edgar","filing":"0000905148-25-001897","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514825001897/form4.xml","form_type":"4"}},{"id":1374134,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-06T20:16:42.000Z","date":"2024-11-05","kind":"purchase","planned":false,"acquired":true,"shares":36000,"price":1.3979,"value":50324.4,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2606879,"source":{"system":"sec-edgar","filing":"0000905148-24-002950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002950/form4.xml","form_type":"4"}},{"id":1374133,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-11-06T20:16:42.000Z","date":"2024-11-05","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.3979,"value":5591.6,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.405, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":89673,"source":{"system":"sec-edgar","filing":"0000905148-24-002950","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824002950/form4.xml","form_type":"4"}},{"id":1498871,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2024-05-29T20:41:20.000Z","date":"2024-05-24","kind":"exercise","planned":false,"acquired":false,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vested on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vested on May 24, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2416},"source":{"system":"sec-edgar","filing":"0000950170-24-066008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000095017024066008/ownership.xml","form_type":"4"}},{"id":1498870,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-29T20:41:20.000Z","date":"2024-05-24","kind":"grant","planned":false,"acquired":true,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":12846,"source":{"system":"sec-edgar","filing":"0000950170-24-066008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000095017024066008/ownership.xml","form_type":"4"}},{"id":1503568,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":7392,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":295680},"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503567,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":false,"shares":1304,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":52160},"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503566,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":37050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":37050,"derivative":{"exercise_price":1.57,"expiration_date":"2034-05-20","underlying":"Common Stock","underlying_shares":37050},"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503565,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-21","kind":"grant","planned":false,"acquired":true,"shares":53726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit (the \"RSU\") represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":53726,"derivative":{"underlying":"Common Stock","underlying_shares":53726},"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503564,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":295680,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2570879,"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503563,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-23T23:15:06.000Z","date":"2024-05-23","kind":"exercise","planned":false,"acquired":true,"shares":52160,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") into shares of the Issuer's common stock (\"Common Stock\") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":85673,"source":{"system":"sec-edgar","filing":"0000905148-24-001615","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001615/form4.xml","form_type":"4"}},{"id":1503348,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2024-05-23T22:29:24.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":4929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 22, 2025."}],"balance_after":4929,"derivative":{"underlying":"Common Stock","underlying_shares":4929},"source":{"system":"sec-edgar","filing":"0000950170-24-064147","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000095017024064147/ownership.xml","form_type":"4"}},{"id":1544480,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:36:01.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":7392,"price":46,"value":340032.0,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":7392,"derivative":{"underlying":"Common Stock","underlying_shares":295680},"source":{"system":"sec-edgar","filing":"0000905148-24-001143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001143/form4.xml","form_type":"4"}},{"id":1544479,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Series A Non-Voting Convertible Preferred Stock","published_at":"2024-04-09T23:36:01.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":1304,"price":46,"value":59984.0,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of Series A Non-Voting Convertible Preferred Stock (\"Preferred Stock\") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the \"Conversion Proposal\"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":1304,"derivative":{"underlying":"Common Stock","underlying_shares":52160},"source":{"system":"sec-edgar","filing":"0000905148-24-001143","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824001143/form4.xml","form_type":"4"}},{"id":1632842,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}}],"security":"Class A Common Stock","published_at":"2024-02-20T17:27:11.000Z","date":"2023-03-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.587,"value":15870.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above."}],"balance_after":1655184,"source":{"system":"sec-edgar","filing":"0001104659-24-025392","document":"tm246490-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465924025392/tm246490-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":1632841,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}}],"security":"Class A Common Stock","published_at":"2024-02-20T17:27:11.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.3539,"value":2707.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account (\"SMA\")."}],"balance_after":1645184,"source":{"system":"sec-edgar","filing":"0001104659-24-025392","document":"tm246490-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465924025392/tm246490-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":1632840,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}}],"security":"Class A Common Stock","published_at":"2024-02-20T17:27:11.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":1.3539,"value":24370.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1643184,"source":{"system":"sec-edgar","filing":"0001104659-24-025392","document":"tm246490-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465924025392/tm246490-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":1632839,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}}],"security":"Class A Common Stock","published_at":"2024-02-20T17:27:11.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.491,"value":14910.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account (\"SMA\")."}],"balance_after":1625184,"source":{"system":"sec-edgar","filing":"0001104659-24-025392","document":"tm246490-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465924025392/tm246490-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":1632838,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"10% owner in previous filing"}}],"security":"Class A Common Stock","published_at":"2024-02-20T17:27:11.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.491,"value":149100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1615184,"source":{"system":"sec-edgar","filing":"0001104659-24-025392","document":"tm246490-2_4aseq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465924025392/tm246490-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2023-02-13"}},{"id":1671560,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2024-01-25T16:12:05.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"By Birchview Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to the shares held by Birchview Fund, LLC in his capacity as the CEO of such entity. The reporting person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":100000,"derivative":{"exercise_price":1.65,"exercise_date":"2024-01-23","expiration_date":"2029-01-23","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-24-006678","document":"tm244005-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006678/tm244005-7_4seq1.xml","form_type":"4"}},{"id":1671559,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-25T16:12:05.000Z","date":"2024-01-23","kind":"purchase","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":false,"nature":"By Birchview Fund, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities are included within 100,000 units of the issuer (the \"Units\") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to the shares held by Birchview Fund, LLC in his capacity as the CEO of such entity. The reporting person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":120682,"source":{"system":"sec-edgar","filing":"0001104659-24-006678","document":"tm244005-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000110465924006678/tm244005-7_4seq1.xml","form_type":"4"}},{"id":1692040,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T21:19:41.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":105389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."}],"balance_after":140036,"derivative":{"underlying":"Common Stock","underlying_shares":105389},"source":{"system":"sec-edgar","filing":"0000905148-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514824000044/form4.xml","form_type":"4"}},{"id":1813783,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":13580,"price":1.62,"value":21999.6,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":33513,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813782,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":140123,"price":1.62,"value":226999.26,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2275199,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813781,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6790,"price":1.62,"value":10999.8,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":119003,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813780,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6790,"price":1.62,"value":10999.8,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":119003,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813779,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6790,"price":1.62,"value":10999.8,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":119003,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813778,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":6790,"price":1.62,"value":10999.8,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":119003,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1813777,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-08-07T21:33:39.000Z","date":"2023-08-03","kind":"grant","planned":false,"acquired":true,"shares":127777,"price":1.62,"value":206998.74,"ownership":{"direct":true},"balance_after":2542928,"source":{"system":"sec-edgar","filing":"0000905148-23-000628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514823000628/form4.xml","form_type":"4"}},{"id":1842389,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-29T17:55:36.000Z","date":"2023-06-28","kind":"grant","planned":false,"acquired":true,"shares":236842,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 28, 2023, the reporting person was granted RSUs which vest in equal amounts each year for 5 years, with the first installment vesting on June 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":236842,"derivative":{"underlying":"Common Stock","underlying_shares":236842},"source":{"system":"sec-edgar","filing":"0001628280-23-023934","document":"wk-form4_1688075727.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023023934/wk-form4_1688075727.xml","form_type":"4"}},{"id":1861904,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-06-08T20:31:00.000Z","date":"2023-06-06","kind":"exercise","planned":false,"acquired":false,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vested on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vested on June 6, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-23-035426","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123035426/doc4.xml","form_type":"4"}},{"id":1861903,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-08T20:31:00.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":10430,"source":{"system":"sec-edgar","filing":"0001209191-23-035426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123035426/doc4.xml","form_type":"4"}},{"id":1872791,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2023-06-01T18:25:27.000Z","date":"2023-05-29","kind":"grant","planned":false,"acquired":true,"shares":78947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 29, 2023, the reporting person was granted RSUs. All of the RSUs shall vest on the first-year anniversary of the Date of Grant (the \"Vesting Date\"), unless Grantee leaves in good standing before 12 months, in which case they will vest pro-rata based on months served. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":78947,"derivative":{"underlying":"Common Stock","underlying_shares":78947},"source":{"system":"sec-edgar","filing":"0001628280-23-020563","document":"wk-form4_1685658315.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828023020563/wk-form4_1685658315.xml","form_type":"4"}},{"id":1877750,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2023-05-26T00:22:28.000Z","date":"2023-05-24","kind":"grant","planned":false,"acquired":true,"shares":2416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 24, 2024."}],"balance_after":2416,"derivative":{"underlying":"Common Stock","underlying_shares":2416},"source":{"system":"sec-edgar","filing":"0001209191-23-032335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123032335/doc4.xml","form_type":"4"}},{"id":1877969,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-25T22:22:00.000Z","date":"2023-05-23","kind":"grant","planned":false,"acquired":true,"shares":34647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's Common Stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2024, of an additional 105,389 RSUs that will vest in full on March 31, 2024, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."}],"balance_after":34647,"derivative":{"underlying":"Common Stock","underlying_shares":34647},"source":{"system":"sec-edgar","filing":"0001140361-23-026719","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123026719/form4.xml","form_type":"4"}},{"id":1882228,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2023-05-22T20:08:35.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0001209191-23-031413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123031413/doc4.xml","form_type":"4"}},{"id":1882227,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2023-05-22T20:08:35.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0001209191-23-031413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123031413/doc4.xml","form_type":"4"}},{"id":1882226,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:08:35.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":8182,"source":{"system":"sec-edgar","filing":"0001209191-23-031413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123031413/doc4.xml","form_type":"4"}},{"id":1882225,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-22T20:08:35.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":8097,"source":{"system":"sec-edgar","filing":"0001209191-23-031413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123031413/doc4.xml","form_type":"4"}},{"id":1891096,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Premium)","published_at":"2023-05-16T22:21:42.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":false,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0001209191-23-029932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123029932/doc4.xml","form_type":"4"}},{"id":1891095,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Converted)","published_at":"2023-05-16T22:21:42.000Z","date":"2023-05-14","kind":"exercise","planned":false,"acquired":false,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and occurred according to the elected deferred schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":875},"source":{"system":"sec-edgar","filing":"0001209191-23-029932","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123029932/doc4.xml","form_type":"4"}},{"id":1891094,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T22:21:42.000Z","date":"2023-05-14","kind":"grant","planned":false,"acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":7670,"source":{"system":"sec-edgar","filing":"0001209191-23-029932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123029932/doc4.xml","form_type":"4"}},{"id":1891093,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-16T22:21:42.000Z","date":"2023-05-14","kind":"grant","planned":false,"acquired":true,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":7408,"source":{"system":"sec-edgar","filing":"0001209191-23-029932","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919123029932/doc4.xml","form_type":"4"}},{"id":1937725,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-27T20:17:11.000Z","date":"2023-03-27","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.587,"value":15870.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above."}],"balance_after":1655184,"source":{"system":"sec-edgar","filing":"0001104659-23-037129","document":"tm2310663-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923037129/tm2310663-1_4seq1.xml","form_type":"4"}},{"id":1937724,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-27T20:17:11.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":1.3539,"value":2707.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account (\"SMA\")."}],"balance_after":1645184,"source":{"system":"sec-edgar","filing":"0001104659-23-037129","document":"tm2310663-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923037129/tm2310663-1_4seq1.xml","form_type":"4"}},{"id":1937723,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-27T20:17:11.000Z","date":"2023-03-24","kind":"purchase","planned":false,"acquired":true,"shares":18000,"price":1.3539,"value":24370.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1643184,"source":{"system":"sec-edgar","filing":"0001104659-23-037129","document":"tm2310663-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923037129/tm2310663-1_4seq1.xml","form_type":"4"}},{"id":1937722,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-27T20:17:11.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.491,"value":14910.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account (\"SMA\")."}],"balance_after":1625184,"source":{"system":"sec-edgar","filing":"0001104659-23-037129","document":"tm2310663-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923037129/tm2310663-1_4seq1.xml","form_type":"4"}},{"id":1937721,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-03-27T20:17:11.000Z","date":"2023-03-23","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":1.491,"value":149100.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1615184,"source":{"system":"sec-edgar","filing":"0001104659-23-037129","document":"tm2310663-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923037129/tm2310663-1_4seq1.xml","form_type":"4"}},{"id":2019492,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":4000,"price":3.7853,"value":15141.2,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"As specified in Table I, Birchview Capital, LP advises the shares in a different SMA other than the one noted above."}],"balance_after":1515184,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2019491,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":9061,"price":3.7939,"value":34376.5279,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the shares in a separately managed account (\"SMA\")."}],"balance_after":1511184,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2019490,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":34000,"price":3.58,"value":121720.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"As specified in Table I, Birchview Capital, LP advises the shares in a separately managed account (\"SMA\")."}],"balance_after":1502123,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2019489,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":10000,"price":3.58,"value":35800.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1468123,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2019488,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":40000,"price":4.75,"value":190000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1458123,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2019487,"issuer":{"id":7342,"kind":"organization","name":"ELUTIA INC.","symbol":"ELUT"},"owners":[{"id":94120,"kind":"organization","name":"Birchview Capital, LP","position":1,"cik":"0001618205","reported_name":"Birchview Capital, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":94121,"kind":"organization","name":"Birchview Fund LLC","position":2,"cik":"0001603544","reported_name":"Birchview Fund LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":42321,"kind":"person","name":"Strobeck Matthew","position":3,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2023-02-14T00:01:15.000Z","date":"2022-05-11","kind":"purchase","acquired":true,"shares":200,"price":5.9604,"value":1192.08,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC (\"the Fund\"). Birchview Capital, LP is the investment manager of the Fund."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund."}],"balance_after":1418123,"source":{"system":"sec-edgar","filing":"0001104659-23-019991","document":"tm236492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000110465923019991/tm236492-1_4seq1.xml","form_type":"4"}},{"id":2062436,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-05T21:31:07.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":6097,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":151930,"derivative":{"underlying":"Common Stock","underlying_shares":6097},"source":{"system":"sec-edgar","filing":"0001140361-23-000666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000666/form4.xml","form_type":"4"}},{"id":2067061,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-04T23:20:34.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Represents deferred RSUs.  The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer."}],"balance_after":145833,"derivative":{"underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001140361-23-000522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036123000522/form4.xml","form_type":"4"}},{"id":2108489,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":1365217,"price":1.15,"value":1569999.55,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":2135076,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2108488,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":108695,"price":1.15,"value":124999.25,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":112213,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2108487,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":108695,"price":1.15,"value":124999.25,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":112213,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2108486,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":108695,"price":1.15,"value":124999.25,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":112213,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2108485,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":108695,"price":1.15,"value":124999.25,"ownership":{"direct":false,"nature":"By UTMA Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":112213,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2108484,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-11-21T23:02:47.000Z","date":"2022-11-21","kind":"purchase","acquired":true,"shares":869565,"price":1.15,"value":999999.75,"ownership":{"direct":true},"balance_after":2415151,"source":{"system":"sec-edgar","filing":"0001140361-22-042597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122042597/form4.xml","form_type":"4"}},{"id":2238807,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2022-06-08T22:20:58.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":2248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on June 6, 2023."}],"balance_after":2248,"derivative":{"underlying":"Common Stock","underlying_shares":2248},"source":{"system":"sec-edgar","filing":"0001209191-22-035180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000120919122035180/doc4.xml","form_type":"4"}},{"id":2248652,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Restricted Stock Units","published_at":"2022-06-02T16:22:50.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":75949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in full on May 31, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. Pursuant to the issuer's Director Equity Deferral Program, the reporting person has elected to defer receipt of the shares of common stock upon vesting of the restricted stock units to such time that is within 30 days following his departure from the issuer's board of directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Not applicable."}],"balance_after":75949,"derivative":{"underlying":"Common Stock","underlying_shares":75949},"source":{"system":"sec-edgar","filing":"0001628280-22-016064","document":"wf-form4_165420133707666.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828022016064/wf-form4_165420133707666.xml","form_type":"4"}},{"id":2249181,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":85,"derivative":{"underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249180,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":427,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249179,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":262,"derivative":{"underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249178,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":875,"derivative":{"underlying":"Common Stock","underlying_shares":875},"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249177,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested in full."}],"balance_after":259,"derivative":{"exercise_price":53.27,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":259},"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249176,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":38145,"ownership":{"direct":false,"nature":"Birchview"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":38145,"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249175,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":16630,"ownership":{"direct":false,"nature":"UGMA Account"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":16630,"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2249174,"issuer":{"id":4986,"kind":"organization","name":"QuidelOrtho Corp","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T21:36:15.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":6533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho."}],"balance_after":6533,"source":{"system":"sec-edgar","filing":"0000899243-22-020490","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377832/000089924322020490/doc4.xml","form_type":"4"}},{"id":2250501,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250500,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":427},"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250499,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":262},"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250498,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each restricted stock unit represents the right to receive one share of Quidel common stock."},{"field":"kind","element":"transactionCoding","label":"F7","text":"Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":875},"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250497,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vested in full."}],"balance_after":0,"derivative":{"exercise_price":53.27,"expiration_date":"2028-04-04","underlying":"Common Stock","underlying_shares":259},"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250496,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":38145,"ownership":{"direct":false,"nature":"Birchview"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250495,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":16630,"ownership":{"direct":false,"nature":"UGMA Account"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2250494,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-01T16:27:47.000Z","date":"2022-05-27","kind":"disposition_to_issuer","acquired":false,"shares":6533,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the \"Business Combination Agreement\") by and among Quidel Corporation (\"Quidel\"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation (\"QuidelOrtho\"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-020410","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000089924322020410/doc4.xml","form_type":"4"}},{"id":2255126,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-26T20:16:12.000Z","date":"2022-05-24","kind":"grant","acquired":true,"shares":83333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock and has no expiration date."},{"field":"shares","element":"transactionShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These RSUs will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Compensation Committee of the Issuer's Board of Directors also approved a grant to the Reporting Person, effective January 1, 2023, of an additional 62,500 RSUs that will vest in full on March 31, 2023, generally subject to the reporting person's continued service with the Issuer. In the event the reporting person's continued service on the Board terminates other than for cause, the option will vest on a prorated basis based on the number of full months of service the reporting person completed during the applicable vesting period."}],"balance_after":83333,"derivative":{"underlying":"Common Stock","underlying_shares":83333},"source":{"system":"sec-edgar","filing":"0001140361-22-020788","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122020788/form4.xml","form_type":"4"}},{"id":2262735,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units (Equity Grant)","published_at":"2022-05-20T19:50:09.000Z","date":"2022-05-18","kind":"exercise","acquired":false,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Quidel Corporation common stock."}],"balance_after":0,"derivative":{"exercise_date":"2022-05-18","expiration_date":"2022-05-18","underlying":"Common Stock","underlying_shares":1624},"source":{"system":"sec-edgar","filing":"0001209191-22-031194","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919122031194/doc4.xml","form_type":"4"}},{"id":2262734,"issuer":{"id":126712,"kind":"organization","name":"QUIDEL CORP /DE/","symbol":"QDEL"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T19:50:09.000Z","date":"2022-05-18","kind":"exercise","acquired":true,"shares":1624,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on Form 4."}],"balance_after":6533,"source":{"system":"sec-edgar","filing":"0001209191-22-031194","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/353569/000120919122031194/doc4.xml","form_type":"4"}},{"id":2299316,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-11T20:36:54.000Z","date":"2022-04-07","kind":"purchase","acquired":true,"shares":558659,"price":1.79,"value":999999.61,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":769859,"source":{"system":"sec-edgar","filing":"0001567619-22-008353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922008353/doc1.xml","form_type":"4"}},{"id":2299315,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-11T20:36:54.000Z","date":"2022-04-07","kind":"purchase","acquired":true,"shares":558659,"price":1.79,"value":999999.61,"ownership":{"direct":true},"balance_after":1545586,"source":{"system":"sec-edgar","filing":"0001567619-22-008353","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922008353/doc1.xml","form_type":"4"}},{"id":2307979,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-04-04T20:15:57.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":20044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vested in full on March 31, 2022 and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vested in full on March 31, 2022 and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20044},"source":{"system":"sec-edgar","filing":"0001140361-22-012920","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122012920/form4.xml","form_type":"4"}},{"id":2307978,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-04-04T20:15:57.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":20044,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":986927,"source":{"system":"sec-edgar","filing":"0001140361-22-012920","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000114036122012920/form4.xml","form_type":"4"}},{"id":2448787,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T22:02:09.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":9100,"price":4.35,"value":39585.0,"ownership":{"direct":false,"nature":"By Birchview Capital Separately Managed Account"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":19933,"source":{"system":"sec-edgar","filing":"0001567619-22-000277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922000277/doc1.xml","form_type":"4"}},{"id":2448786,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T22:02:09.000Z","date":"2021-12-30","kind":"purchase","acquired":true,"shares":138700,"price":4.35,"value":603345.0,"ownership":{"direct":false,"nature":"By Birchview Fund LLC"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":211200,"source":{"system":"sec-edgar","filing":"0001567619-22-000277","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000156761922000277/doc1.xml","form_type":"4"}},{"id":2478266,"issuer":{"id":78156,"kind":"organization","name":"Accelerate Diagnostics, Inc","symbol":"AXDX"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-10T16:01:08.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":19531,"price":7.68,"value":149998.08,"ownership":{"direct":false,"nature":"By Birchview Fund, LLC"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. in connection with the closing of the third and final tranche of an offering exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 promulgated thereunder. The third and final tranche of the offering closed on September 30, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person has sole voting and dispositive power with respect to the shares held by Birchview Fund, LLC in his capacity as the CEO of such entity. The reporting person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":206828,"source":{"system":"sec-edgar","filing":"0001628280-21-024840","document":"wf-form4_163917005520386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/727207/000162828021024840/wf-form4_163917005520386.xml","form_type":"4"}},{"id":2647491,"issuer":{"id":6053,"kind":"organization","name":"BIODESIX INC"},"owners":[{"id":42321,"kind":"person","name":"Strobeck Matthew","position":1,"cik":"0001377832","reported_name":"Strobeck Matthew","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-07-01T22:26:17.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":20044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will vest in full on March 31, 2022 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will vest in full on March 31, 2022 and have no expiration date."}],"balance_after":20044,"derivative":{"underlying":"Common Stock","underlying_shares":20044},"source":{"system":"sec-edgar","filing":"0000905148-21-000541","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1439725/000090514821000541/form4.xml","form_type":"4"}}],"next_cursor":"2021-07-01T22:26:17.000000Z,2647491"}